title: A clinicopathologic study on patients with endometrial cancer after adjuvant tamoxifen treatment for breast cancer: a single center experience.
authors.forename: Panagiota
authors.initials: P
authors.lastname: Ravazoula
authors.forename: Georgios
authors.initials: G
authors.lastname: Androutsopoulos
authors.forename: Paraskevi
authors.initials: P
authors.lastname: Zyli
authors.forename: Georgios
authors.initials: G
authors.lastname: Michail
authors.forename: Dimitrios M
authors.initials: DM
authors.lastname: Kardamakis
authors.forename: Georgios
authors.initials: G
authors.lastname: Kourounis
mesh_terms: D000368:Aged; D018931:Antineoplastic Agents, Hormonal / Q000009:adverse effects* / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy*; D016889:Endometrial Neoplasms / Q000139:chemically induced* / Q000401:mortality / Q000473:pathology; D005260:Female; D006801:Humans; D008875:Middle Aged; D017698:Postmenopause; D015996:Survival Rate; D013629:Tamoxifen / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D018931:Antineoplastic Agents, Hormonal; D013629:Tamoxifen